- Home
- GANX vs WWR Comparison
GANX vs WWR Comparison
Compare GANX & WWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GANX
- WWR
- Stock Information
- Founded
- GANX 2017
- WWR 1977
- Country
- GANX United States
- WWR United States
- Employees
- GANX N/A
- WWR N/A
- Industry
- GANX Biotechnology: Pharmaceutical Preparations
- WWR Metal Mining
- Sector
- GANX Health Care
- WWR Basic Materials
- Exchange
- GANX Nasdaq
- WWR Nasdaq
- Market Cap
- GANX 41.9M
- WWR 33.7M
- IPO Year
- GANX 2021
- WWR N/A
- Fundamental
- Price
- GANX $1.85
- WWR $0.54
- Analyst Decision
- GANX Strong Buy
- WWR
- Analyst Count
- GANX 4
- WWR 0
- Target Price
- GANX $7.75
- WWR N/A
- AVG Volume (30 Days)
- GANX 281.8K
- WWR 665.6K
- Earning Date
- GANX 11-14-2024
- WWR 11-15-2024
- Dividend Yield
- GANX N/A
- WWR N/A
- EPS Growth
- GANX N/A
- WWR N/A
- EPS
- GANX N/A
- WWR N/A
- Revenue
- GANX N/A
- WWR N/A
- Revenue This Year
- GANX N/A
- WWR N/A
- Revenue Next Year
- GANX $300.03
- WWR N/A
- P/E Ratio
- GANX N/A
- WWR N/A
- Revenue Growth
- GANX N/A
- WWR N/A
- 52 Week Low
- GANX $0.89
- WWR $0.40
- 52 Week High
- GANX $5.33
- WWR $0.78
- Technical
- Relative Strength Index (RSI)
- GANX 39.86
- WWR 43.21
- Support Level
- GANX $1.64
- WWR $0.55
- Resistance Level
- GANX $2.34
- WWR $0.60
- Average True Range (ATR)
- GANX 0.27
- WWR 0.03
- MACD
- GANX -0.09
- WWR -0.01
- Stochastic Oscillator
- GANX 19.90
- WWR 12.70
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.
About WWR Westwater Resources Inc.
Westwater Resources Inc focused on developing battery-grade natural graphite materials. The company is having one project which is the Westwater's coosa project which is currently used for the mining and extraction of graphite.